Drugs and devices synergy: optimal DAPT & switching strategies - Round Table Webinar
Entering the TWILIGHT zone of DAPT duration
CRT 2020: Duration of DAPT treatment in ST prevention — Prof Dean J Kereiakes
One month DAPT is “becoming standard of care” for high bleeding risk patients following PCI
Antiplatelet therapy peri-PCI: acute and long-term management- Elias Hanna, Univ Iowa
One month DAPT is the new standard of care for stable patients?_Baber_Coronary On Demand
DAPT challenges in complex clinical scenarios
What you need to know about DAPT in high-bleeding risk patients - GulfPCR-GIM 2020
Complex PCI in high bleeding risk patients
EuroPCR 2016: Master DAPT study announcement
AsiaIntervention Will the DAPT trial change my practice? The Asian perspective
Prolonged DAPT – Where Do We Stand Post PEGASUS & DAPT Trials? Prof. Shlomi Matetzky
What matters to patients matters to you: 2020 hot topics – AICT-AsiaPCR 2020
How should I treat a patient at high bleeding risk requiring complex PCI? - Webinar
Controversies in Antiplatelet Therapy for the Secondary Prevention of Cardiovascular Events
Evidence counts: Latest data from Onyx One-month DAPT program & Renal Denervation – GulfPCR-GIM 2020
CCC 2019: THE GREAT DEBATE: ASPIRIN, DAPT OR DPI FOR SECONDARY PREVENTION IN STABLE ASCVD PATIENTS?
Pharmacology during coronary revascularization
What Science ACTUALLY Says About TB 500 Benefits
Updates to Dual Antiplatelet Therapy
